Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 216148, 9 pages
http://dx.doi.org/10.1093/ecam/nep216
Original Article

RSC96 Schwann Cell Proliferation and Survival Induced by Dilong through PI3K/Akt Signaling Mediated by IGF-I

1Graduate Institute of Chinese Medical Science and Institute of Basic Medical Science, China Medical University, No 91, Hsueh-Shih Road, Taichung 404, Taiwan
2School of Chinese Medicine, China Medical University, Taiwan
3Division of Gastroenterology, Department of Internal Medicine, Armed-Force, Taichung General Hospital, Taiwan
4School of Post-Baccalaureate Chinese Medicine, Taiwan
5Department of Pediatrics, Medical Research and Medical Genetics, China Medical University, Taiwan
6Department of Healthcare Administration, Asia University, Taiwan
7Departments of Internal Medicine, Taiwan
8Department of Orthopedics, Armed Force, Taichung General Hospital, Taiwan
9Department of Biological Science and Technology, China Medical University, Taiwan
10Graduate Institute of Basic Medical Science, China Medical University, Taiwan
11Department of Health and Nutrition Biotechnology, Asia University, Taichung, Taiwan

Received 27 May 2009; Accepted 19 November 2009

Copyright © 2011 Yung-Ming Chang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. P. Bunge, “Expanding roles for the Schwann cell: ensheathment, myelination, trophism and regeneration,” Current Opinion in Neurobiology, vol. 3, no. 5, pp. 805–809, 1993. View at Publisher · View at Google Scholar · View at Scopus
  2. J. W. Fawcett and R. J. Keynes, “Peripheral nerve regeneration,” Annual Review of Neuroscience, vol. 13, pp. 43–60, 1990. View at Google Scholar · View at Scopus
  3. R. P. Bunge, “The role of the Schwann cell in trophic support and regeneration,” Journal of Neurology, vol. 242, no. 1, supplement, pp. S19–S21, 1994. View at Google Scholar · View at Scopus
  4. M. Schumacher, I. Jung-Testas, P. Robel, and E. E. Baulieu, “Insulin-like growth factor I: a mitogen for rat Schwann cells in the presence of elevated levels of cyclic AMP,” Glia, vol. 8, no. 4, pp. 232–240, 1993. View at Google Scholar · View at Scopus
  5. D. Le Roith and A. A. Butler, “Insulin-like growth factors in pediatric health and disease,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 12, pp. 4355–4361, 1999. View at Google Scholar · View at Scopus
  6. K. Zackenfels, R. W. Oppenheim, and H. Rohrer, “Evidence for an important role of IGF-I and IGF-II for the early development of chick sympathetic neurons,” Neuron, vol. 14, no. 4, pp. 731–741, 1995. View at Google Scholar · View at Scopus
  7. E. Cicco-Bloom and I. B. Black, “Insulin growth factors regulate the mitotic cycle in cultured rat sympathetic neuroblasts,” Proceedings of the National Academy of Sciences of the Unites States of America, vol. 85, pp. 4066–4070, 1988. View at Google Scholar
  8. Y. Aizenman and V. J. de, “Brain neurons develop in a serum and glial free environment: effects of transferrin, insulin, insulin-like growth factor-I and thyroid hormone on neuronal survival, growth and differentiation,” Brain Research, vol. 406, pp. 32–42, 1987. View at Google Scholar
  9. P. Caroni and P. Grandes, “Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors,” Journal of Cell Biology, vol. 110, no. 4, pp. 1307–1317, 1990. View at Google Scholar · View at Scopus
  10. J. I. Jones and D. R. Clemmons, “Insulin-like growth factors and their binding proteins: biological actions,” Endocrine Reviews, vol. 16, no. 1, pp. 3–34, 1995. View at Google Scholar · View at Scopus
  11. G. Mairet-Coello, A. Tury, and E. Cicco-Bloom, “Insulin-like growth factor-1 promotes G(1)/S cell cycle progression through bidirectional regulation of cyclins and cyclin-dependent kinase inhibitors via the phosphatidylinositol 3-kinase/Akt pathway in developing rat cerebral cortex,” The Journal of Neuroscience, vol. 29, pp. 775–788, 2009. View at Google Scholar
  12. J. G. Gong, D. McBride, T. A. Bramley, and R. Webb, “Effects of recombinant bovine somatotrophin, insulin-like growth factor-I and insulin on the proliferation of bovine granulosa cells in vitro,” Journal of Endocrinology, vol. 139, pp. 67–75, 1993. View at Google Scholar
  13. K. A. Sullivan, B. Kim, and E. L. Feldman, “Insulin-like growth factors in the peripheral nervous system,” Endocrinology, vol. 149, no. 12, pp. 5963–5971, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. G. M. Leinninger, C. Backus, M. D. Uhler, S. I. Lentz, and E. L. Feldman, “Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons,” FASEB Journal, vol. 18, no. 13, pp. 1544–1546, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. W. M. Campana, S. J. Darin, and J. S. O'Brien, “Phosphatidylinositol 3-kinase and Akt protein kinase mediate IGF-I- and prosaptide-induced survival in Schwann cells,” Journal of Neuroscience Research, vol. 57, no. 3, pp. 332–341, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Koriyama, K. Homma, K. Sugitani et al., “Upregulation of IGF-I in the goldfish retinal ganglion cells during the early stage of optic nerve regeneration,” Neurochemistry International, vol. 50, no. 5, pp. 749–756, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Maurel and J. L. Salzer, “Axonal regulation of Schwann cell proliferation and survival and the initial events of myelination requires PI 3-kinase activity,” Journal of Neuroscience, vol. 20, no. 12, pp. 4635–4645, 2000. View at Google Scholar · View at Scopus
  18. C.-C. Tsai, M.-C. Lu, Y.-S. Chen, C.-H. Wu, and C.-C. Lin, “Locally administered nerve growth factor suppresses ginsenoside Rb 1-enhanced peripheral nerve regeneration,” American Journal of Chinese Medicine, vol. 31, no. 5, pp. 665–673, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Balamurugan, K. Parthasarathi, L. S. Ranganathan, and E. L. Cooper, “Hypothetical mode of action of earthworm extract with hepatoprotective and antioxidant properties,” Journal of Zhejiang University: Science B, vol. 9, no. 2, pp. 141–147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. E. L. Cooper, “Bioprospecting: a CAM frontier,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 1, pp. 1–3, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. G. H. Ryu, S. Park, D. K. Han, Y. H. Kim, and B. Min, “Antithrombotic activity of a lumbrokinase immobilized polyurethane surface,” ASAIO Journal, vol. 39, no. 3, pp. M314–M318, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. E. L. Cooper, B. Ru, and N. Weng, “Earthworms: sources of antimicrobial and anticancer molecules,” Advances in Experimental Medicine and Biology, vol. 546, pp. 359–389, 2004. View at Google Scholar · View at Scopus
  23. M. Zhang, X. Li, Y. Liu, F. Ye, and G. Qiu, “Effects of extract of Dilong (Pheretima) on the scalded skin in rats,” Journal of Traditional Chinese Medicine, vol. 26, no. 1, pp. 68–71, 2006. View at Google Scholar · View at Scopus
  24. E. L. Cooper, “Complementary and alternative medicine, when rigorous, can be science,” Evidence-Based Complementary and Alternative Medicine, vol. 1, pp. 1–4, 2004. View at Google Scholar
  25. L. Jin, H. Jin, G. Zhang, and G. Xu, “Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase,” Clinical Hemorheology And Microcirculation, vol. 23, pp. 213–218, 2000. View at Google Scholar
  26. T. Hrzenjak, M. Popovic, T. Bozic, M. Grdisa, D. Kobrehel, and L. Tiska-Rudman, “Fibrinolytic and anticoagulative activities from the earthworm Eisenia foetida,” Comparative Biochemistry and Physiology. B, vol. 119, no. 4, pp. 825–832, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Hrzenjak, D. Kobrehel, S. Levanat, M. Jurin, and T. Hrzenjak, “Mitogenicity of the earthworm's (Eisenia foetida) insulin-like proteins,” Comparative Biochemistry and Physiology. B, vol. 104, no. 4, pp. 723–729, 1993. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Popovic, T. M. Hrcenjak, T. Babic, J. Kos, and M. Grdisa, “Effect of earthworm (G-90) extract on formation and lysis of clots originated from venous blood of dogs with cardiopathies and with malignant tumors,” Pathology and Oncology Research, vol. 7, pp. 197–202, 2001. View at Google Scholar
  29. M. Popovic, T. Hrzenjak, M. Grdiša, and S. Vuković, “Adhesins of immunoglobulin-like superfamily from earthworm Eisenia foetida,” General Pharmacology, vol. 30, no. 5, pp. 795–800, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. E. L. Cooper, T. M. Hrzenjak, and M. Grdiša, “Alternative sources of fibrinolytic, anticoagulative, antimicrobial and anticancer molecules,” International Journal of Immunopathology and Pharmacology, vol. 17, no. 3, pp. 237–244, 2004. View at Google Scholar · View at Scopus
  31. W. D. Snider, F.-Q. Zhou, J. Zhong, and A. Markus, “Signaling the pathway to regeneration,” Neuron, vol. 35, no. 1, pp. 13–16, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. E. L. Cooper, “CAM, eCAM, bioprospecting: the 21st century pyramid,” Evidence-Based Complementary and Alternative Medicine, vol. 2, no. 2, pp. 125–127, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Grdiša, M. Popovic, and T. Hrzenjak, “Stimulation of growth factor synthesis in skin wounds using tissue extract (G-90) from the earthworm Eissenia foetida,” Cell Biochemistry and Function, vol. 22, no. 6, pp. 373–378, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Wei, P. Zhang, Y. Dang, H. Zhang, and B. Jiang, “Primary study on effect of various components of modified formula radix hedysari on peripheral nerve regeneration,” Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, vol. 22, no. 9, pp. 1056–1059, 2008. View at Google Scholar · View at Scopus
  35. E.-J. Huang, C.-C. Wu, H.-P. Huang et al., “Apoptotic and anti-proliferative effects of 17β-estradiol and 17β-estradiol-like compounds in the Hep3B cell line,” Molecular and Cellular Biochemistry, vol. 290, no. 1-2, pp. 1–7, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. M. Chang, Y. T. Shih, Y. S. Chen, C. L. Liu, W. K. Fang, and C. H. Tsai, “Schwann cell migration induced by earthworm extract via activation of PAs and MMP2/9 mediated through ERK1/2 and p38,” Evidence-Based Complementary and Alternative Medicine. View at Publisher · View at Google Scholar
  37. S. Geuna, S. Raimondo, S. Nicolino et al., “Schwann-cell proliferatin in muscle-vein combined conduits for bridging rat sciatic nerve defects,” Journal of Reconstructive Microsurgery, vol. 19, no. 2, pp. 119–123, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. H. Y. Zhang and X. C. Tang, “Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease,” Trends in Pharmacological Sciences, vol. 27, no. 12, pp. 619–625, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. D. Bensky and A. Gamble, Chinese Herbal Medicine. Materia Medica, Eastland Press, Seattle, Wash, USA, 1993.
  40. Z. X. Zhang and F. F. Wang, “Effects of crude extract of earthworm on promoting blood circulation to removing stasis,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 12, no. 12, pp. 741–710, 1992. View at Google Scholar · View at Scopus
  41. H. Mihara, H. Sumi, T. Yoneta et al., “A novel fibrinolytic enzyme extracted from the earthworm, Lumbricus rubellus,” Japanese Journal of Physiology, vol. 41, no. 3, pp. 461–472, 1991. View at Google Scholar · View at Scopus
  42. H. Ji, L. Wang, H. Bi, L. Sun, B. Cai, and Y. Wang, “Mechanisms of lumbrokinase in protection of cerebral ischemia,” European Journal of Pharmacology, vol. 590, pp. 281–289, 2008. View at Google Scholar
  43. H. Chen, S. Takahashi, M. Imamura et al., “Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo,” Chinese Medical Journal, vol. 120, no. 10, pp. 898–904, 2007. View at Google Scholar · View at Scopus
  44. E. L. Cooper, M. Balamurugan, K. Parthasarathi, and L. S. Ranganathan, “Earthworm paste (Lampito mauritii, Kinberg) alters inflammatory, oxidative, haematological and serum biochemical indices of inflamed rat,” European Review for Medical and Pharmacological Sciences, vol. 11, no. 2, pp. 77–90, 2007. View at Google Scholar · View at Scopus
  45. M. Grdisa, M. Popovic, and T. Hrzenjak, “Glycolipoprotein extract (G-90) from earthworm Eisenia foetida exerts some antioxidative activity,” Comparative Biochemistry and Physiology. A, vol. 128, no. 4, pp. 821–825, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Gutmann and J. Zelena, “Morphological changes in the denervated muscle,” in The Denervated Muscle, E. Gutmann, Ed., pp. 57–102, Publishing House of the Czechoslovak Academy of Sciences, Prague, Czech Republic, 1962. View at Google Scholar
  47. D. N. Ishii, B. G. W. Glazner, and L. R. Whalen, “Regulation of peripheral nerve regeneration by insulin-like growth factors,” Annals of the New York Academy of Sciences, vol. 692, pp. 172–182, 1993. View at Google Scholar · View at Scopus
  48. M. Savignat, L. De-Doncker, C. Vodouhe, J. M. Garza, P. Lavalle, and P. Libersa, “Rat nerve regeneration with the use of a polymeric membrane loaded with NGF,” Journal of Dental Research, vol. 86, no. 11, pp. 1051–1056, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. R. M. Grumbles, S. Sesodia, P. M. Wood, and C. K. Thomas, “Neurotrophic factors improve motoneuron survival and function of muscle reinnervated by embryonic neurons,” Journal of Neuropathology and Experimental Neurology, vol. 68, no. 7, pp. 736–746, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. N. M. Geremia, L. M. E. Pettersson, J. C. Hasmatali et al., “Endogenous BDNF regulates induction of intrinsic neuronal growth programs in injured sensory neurons,” Experimental Neurology, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. D. N. Ishii, G. W. Glazner, and S.-F. Pu, “Role of insulin-like growth factors in peripheral nerve regeneration,” Pharmacology and Therapeutics, vol. 62, no. 1-2, pp. 125–144, 1994. View at Publisher · View at Google Scholar · View at Scopus
  52. S. L. Near, L. R. Whalen, J. A. Miller, and D. N. Ishii, “Insulin-like growth factor II stimulates motor nerve regeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 24, pp. 11716–11720, 1992. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Kanje, A. Skottner, J. Sjoberg, and G. Lundborg, “Insulin-like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve,” Brain Research, vol. 486, no. 2, pp. 396–398, 1989. View at Google Scholar · View at Scopus
  54. H.-A. Hansson, “Insulin-like growth factors and nerve regeneration,” Annals of the New York Academy of Sciences, vol. 692, pp. 161–171, 1993. View at Google Scholar · View at Scopus
  55. S.-F. Pu, H.-X. Zhuang, and D. N. Ishii, “Differential spatio-temporal expression of the insulin-like growth factor genes in regenerating sciatic nerve,” Molecular Brain Research, vol. 34, no. 1, pp. 18–28, 1995. View at Publisher · View at Google Scholar · View at Scopus
  56. B. Anlar, K. A. Sullivan, and E. L. Feldman, “Insulin-like growth factor-I and central nervous system development,” Hormone and Metabolic Research, vol. 31, no. 2-3, pp. 120–125, 1999. View at Google Scholar · View at Scopus
  57. C.-L. Hu, R. G. Cowan, R. M. Harman, and S. M. Quirk, “Cell cycle progression and activation of Akt kinase are required for insulin-like growth factor I-mediated suppression of apoptosis in granulosa cells,” Molecular Endocrinology, vol. 18, no. 2, pp. 326–338, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. W. M. Campana, S. J. Darin, and J. S. O'Brien, “Phosphatidylinositol 3-kinase and Akt protein kinase mediate IGF-I- and prosaptide-induced survival in Schwann cells,” Journal of Neuroscience Research, vol. 57, no. 3, pp. 332–341, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. K. Homma, Y. Koriyama, K. Mawatari, Y. Higuchi, J. Kosaka, and S. Kato, “Early downregulation of IGF-I decides the fate of rat retinal ganglion cells after optic nerve injury,” Neurochemistry International, vol. 50, pp. 741–748, 2007. View at Google Scholar
  60. C. L. Delaney, H.-L. Cheng, and E. L. Feldman, “Insulin-like growth factor-I prevents caspasemediated apoptosis in Schwann cells,” Journal of Neurobiology, vol. 41, no. 4, pp. 540–548, 1999. View at Google Scholar · View at Scopus
  61. C. J. Sherr, “G1 phase progression: cycling on cue,” Cell, vol. 79, no. 4, pp. 551–555, 1994. View at Publisher · View at Google Scholar · View at Scopus
  62. V. A Flørenes, G. M. Mælandsmo, R. Faye, J. M. Nesland, and R. Holm, “Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome,” Journal of Pathology, vol. 195, no. 5, pp. 530–536, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. D. H. Walker and J. L. Maller, “Role for cyclin A in the dependence of mitosis on completion of DNA replication,” Nature, vol. 354, no. 6351, pp. 314–317, 1991. View at Publisher · View at Google Scholar · View at Scopus
  64. D. R. Clemmons, J. J. Van Wyk, and W. J. Pledger, “Sequential addition of platelet factor and plasma to BALB/c 3T3 fibroblast cultures stimulates somatomedin-C binding early in cell cycle,” Proceedings of the National Academy of Sciences of the United States of America, vol. 77, pp. 6644–6648, 1980. View at Google Scholar
  65. N. E. Olashaw, J. J. Van Wyk, and W. J. Pledger, “Control of late G0/G1 progression and protein modification by SmC/IGF I,” The American Journal of Physiology, vol. 253, no. 4, pp. C575–C579, 1987. View at Google Scholar · View at Scopus
  66. M. A. Stull, M. M. Richert, A. V. Loladze, and T. L. Wood, “Requirement for IGF-I in epidermal growth factor-mediated cell cycle progression of mammary epithelial cells,” Endocrinology, vol. 143, no. 5, pp. 1872–1879, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Le Roith and A. A. Butler, “Insulin-like growth factors in pediatric health and disease,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 12, pp. 4355–4361, 1999. View at Google Scholar · View at Scopus
  68. G. T. Williams, C. A. Smith, E. Spooncer, T. M. Dexter, and D. R. Taylor, “Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis,” Nature, vol. 343, no. 6253, pp. 76–79, 1990. View at Publisher · View at Google Scholar · View at Scopus
  69. S. R. Datta, H. Dudek, T. Xu et al., “Akt phosphorylation of BAD couples survival signals to the cell- intrinsic death machinery,” Cell, vol. 91, no. 2, pp. 231–241, 1997. View at Publisher · View at Google Scholar · View at Scopus